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The tumor suppressor p53 locates at the key point of cell growth or apoptosis balance, and the expression level of p53 is tightly 
controlled by ubiquitin ligases including MDM2. Upon DNA damage stresses, p53 was accumulated and activated, leading to cell 
cycle arrest or apoptosis. We previously showed that Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degrada-
tion by interacting with and stabilizing MDM2, and consequently enhancing MDM2-mediated ubiquitylation of p53. However, it 
is unclear how the Smurf1-MDM2 interaction is regulated in response to DNA damage stress. Here, we show that in response to 
etoposide treatment Smurf1 dissociates from MDM2, resulting in MDM2 destabilization and p53 accumulation. The negative 
regulation of Smurf1 on apoptosis is released. Notably, this dissociation is a slow process rather than a rapid response, implicating 
high expression of Smurf1 might confer the resistance against p53 activation. Consistent with this notion, we observed that 
Smurf1/2 ligases are highly expressed in colon cancer, esophageal squamous cell carcinoma and pancreatic cancer tissues, sug-
gesting the oncogenic tendency of Smurf1/2. 
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Protein modification post-translation is a critical molecular 
event in the cellular response to DNA damage, which re-
sults in activation, inactivation and degradation of some 
important components of DNA damage responses. Ubiq-
uitylation is a prominent post-translational protein modifi-
cation that leads to protein degradation, endocytosis, traf-
ficking of transmembrane proteins. It consists of the cova-
lent attachment of the small protein ubiquitin to target pro-
teins, thereby modifying their biochemical properties and 
protein partners [1]. E3 ubiquitin ligases are final effectors 
of the enzyme cascade controlling ubiquitylation [2]. Two 
main classes of E3s are found, the RING (really interesting  
new gene) type and the HECT (homologous to E6AP C- 
terminus) type. The Nedd4 (Neural precursor cell-expressed 
developmentally downregulated 4) family of HECT domain 
E3s typically regulate the stability of both transmembrane 
receptors and intracellular substrates and endocytosis and 
trafficking of plasma membrane proteins [3]. Several Nedd4 
family members affect key signalling pathways, such as 
cellular growth and proliferation [1]. For example, Smurf1 
and Smurf2 also play key roles in TGF-/BMP and MEKK2- 
JNK signalling, controlling bone development, cell polarity 
and motility [4–9]. Recently, we have demonstrated a criti-
cal role of Smurf1/2 in stabilizing the RING type E3 
MDM2 (murine double minute 2), which promotes p53 
degradation and regulates cell apoptosis [10]. 
The p53 tumor suppressor gene encodes a transcriptional 
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regulator that controls cell cycle progression and apoptosis 
[11]. In response to DNA damage or cell stress, p53 acti-
vates and initiates a cascade of events that block cell divi-
sion and/or apoptosis. There are many chemotherapeutic 
agents activate p53 and induce apoptosis in a wide range of 
human cancer cells [12–14]. We recently identified Smurf1/2 
as a novel negative regulator of p53 by enhancing the sta-
bility and trans-E3 ligase activity of MDM2. In unstressed 
cells, Smurf1/2 stabilizes MDM2 by enhancing the hetero-
dimerization of MDM2 with MDMX, which inhibits the 
autoubiquitylation of MDM2 [10]. However, it is unclear 
how the Smurf1-MDM2 interaction is regulated in response 
to DNA damage stress. 
In this study, we showed that Smurf1 dissociated from 
MDM2 and the regulation of Smurf1 on MDM2-p53 was 
abolished in response to DNA damage. Notably, this disso-
ciation is a slow process rather than a rapid response. Upon 
a short time treatment with etoposide, Smurf1 could still 
stabilize MDM2 protein. Moreover, we detected the expres-
sion of Smurf1/2 in some types of tumor samples, bringing 
up the possibility that Smurf1/2 might exhibit some onco-
genic activities. 
1  Materials and methods 
1.1  Plasmids, reagents and antibodies 
6Myc-Smurf1 wild-type, 6Myc-Smurf1-C699A and Flag- 
Smurf1 were described previously [10]. Truncating muta-
tions of Smurf1 were created by inserting PCR-amplified 
fragments into the related vectors. Anti-Myc antibody was 
purchased from ClonTech (BD Biosciences). The protein 
synthesis inhibitor cycloheximide (CHX) was from Sigma. 
The following antibodies were obtained from Santa Cruz Bio-
technology: antibodies against p53 (DO-1), MDM2 (SMP14), 
GAPDH (6C5).  
1.2  Cell culture 
Human breast cancer MCF-7 cells were maintained in a 
DMEM medium supplemented with 10% fetal bovine se-
rum, penicillin, streptomycin, and glutamine, in a humidi-
fied atmosphere of 5% CO2 at 37°C. 
1.3  Immunoprecipitation and immunoblotting 
Transfections were performed with Lipofectamine 2000 
according to the manufacture’s instructions. In order to de-
termine the interaction between Smurf1 and MDM2, im-
munoprecipitation and immunoblotting were performed as 
described previously [10]. 
1.4  Immunohistochemical staining 
A tissue array of multiple human colorectal cancers was 
made from 31 cases of formalin-fixed paraffin-embedded 
colon cancer tissues and their normal tissues counterparts 
from patients underwent surgery resection in Cancer Insti-
tute and Hospital of Chinese Academy of Medical Sciences 
(Beijing, China) during the period of June 2001 to Novem-
ber 2003. All samples were collected after obtaining in-
formed consent and approval from the Institutional Review 
Board. The other kinds of human multiple tissue arrays 
(MTA) of esophageal squamous cell carcinoma (ESCC) 
(OD-CT-DgEso 03-002) and pancreatic cancer (OD-CT- 
DgPan 03-002) were purchased from Shanghai Outdo Bio-
tech (Shanghai, China). The clinical characteristics of all of 
samples are included in Table 1. 
Various cancer tissues and their normal tissues counter-
parts on multiple tissue arrays (MTAs) were incubated sim-
ultaneously with MDM2 (2 g/mL), Smurf1 (4 g/mL), 
Smurf2 (4 g/mL) antibodies or relative control IgG over-
night at 4°C. After washing with PBS, they were reacted 
with the biotin-labeled second antibody and then visualized 
using an ultrasensitive streptavidin-peroxidases system 
(Maxim Biotech, Fuzhou, China). The intensity of MDM2, 
Smurf1 and Smurf2 for each individual case was quantified 
as described previously [15] and the percentage of expres-
sion were both graded as different scores. If the numerical 
value was higher or lower than that of the adjacent normal 
tissue, the expression of MDM2, Smurf1 and Smurf2 in the 
tumor tissue was considered to be up-/down-regulated, re-
spectively. 
1.5  Annexin V-PI staining 
Etoposide-induced cell death was determined by an Annexin  
Table 1  Smurf1/Smurf2 and MDM2 expression in human cancer tissues 
 Smurf1 expression  Smurf2 expression  MDM2 expression 
 Up-regulated Down-regulated  Up-regulated Down-regulated  Up-regulated Down-regulated 
Colorectal Cancer 65.0% (13/20) 35.0% (7/20) 85.0% (17/20) 15.0% (3/20)  70.8% (17/24) 29.2% (7/24) 
ESCC 78.1% (25/32) 21.9% (7/32) 62.5% (20/32) 37.5% (12/32)  68.8% (22/32) 31.2% (10/32) 
Pancreatic Cancer 87.5% (21/24) 12.5% (3/24) 71.2% (16/21) 28.8% (5/21)  66.7% (16/24) 33.3% (8/24) 
Total 77.6% (59/76) 22.4% (17/76) 72.6% (53/73) 27.4% (20/73)  68.8% (55/80) 31.2% (25/80) 
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V-PI kit according to the manufacture’s instructions. MCF- 
7 cells incubated with etoposide (40 mol/L) or DMSO for 
the indicated hours were harvested and twice washed with 
cold phosphate buffered saline (PBS). Cells were resus-
pended in binding buffer, treated with annexin V and propid-
ium iodide (PI), and were analyzed on the FACA Calibur. 
1.6  RNA interference 
The Smurf1 siRNA (5′-UUCUCCGAACGUGUCACGU-3′), 
Smurf2 siRNA (5′-CCUUCUGUGUUGAACAUAA-3′), and 
non-targeting siRNAs (5′-UUCUCCGAACGUGUCACGU- 
3′) were synthesised by Shanghai GenePharm. All siRNA 
transfections were performed with Lipofectamine 2000 
(Invitrogen), and the RNA interference efficiency was as-
sessed by western blot analysis. 
2  Results 
2.1  Combination of either the N-lobe or the C-lobe of 
Smurf1 HECT with WW2 was sufficient to stabilize 
MDM2 
We previously showed that ubiquitin ligase Smurf1 inter-
acts with MDM2 through its WW2 domain and this interac-
tion is required for MDM2 stabilization by Smurf1 [10]. 
The C-terminal HECT domain of Smurf1 is required for this 
process, although the ubiquitin ligase activity of Smurf1 is 
not necessary [10]. Consistent with this notion, overexpres-
sion of WW plus HECT domain with MDM2 resulted in a 
dramatic stabilization of MDM2 (Figure 1(a), lane 5), where-
as overexpression of either HECT or WW domain alone, or 
a ∆HECT deletion mutant only slightly increased the pro-
tein level of MDM2 (Figure 1(a), lanes 2, 3 and 6). The 
ubiquitin ligase-inactive mutant C699A of Smurf1 had sim-
ilar stabilizing effect to wild-type Smurf1 on MDM2 (Fig-
ure 1(a), lanes 7 and 8). A typical HECT domain consists of 
an N-terminal lobe and a C-terminal lobe connected by a 
short hinge (605–607 aa of Smurf1), including the Smurf1/2 
HECT. To further investigate whether the N-lobe or the 
C-lobe of Smurf1 is involved in MDM2 regulation, a series 
of Smurf1 mutants were generated and coexpressed with 
MDM2. Notably, the combination of either the N-lobe or 
the C-lobe of HECT with WW2 was sufficient to stabilize 
MDM2 (Figure 1(a), lanes 10–12 vs lane 9). Therefore, on 
the one hand, both the WW2 and the HECT domains are 
required for Smurf1 to stabilize MDM; on the other hand, 
either the N-lobe or the C-lobe of HECT was sufficient to 
coordinate with WW2 of Smurf1 to stabilize MDM2 (Fig-
ure 1(b)). 
2.2  Smurf1 dissociates from MDM2 gradually in  
response to DNA damage 
MDM2 is a short-lived protein due to its autoubiquitylation 
and proteasomal degradation. To ensure the p53 accumula-
tion and activation, MDM2 itself is degraded rapidly fol-
lowing DNA damage. We next examined whether the stabi-
lizing activity of Smurf1 on MDM2 was inactivated by 
DNA damage. After etoposide treatment, p53 was signifi-
cantly accumulated whereas MDM2 was degraded (Figure 
2(a), lane 3 vs lane 1). In the presence of ectopic Smurf1, 
under unstressed conditions Smurf1 stabilized MDM2 (Fig-
ure 2(a), lane 2 vs lane 1, MDM2 panel); upon etoposide 
treatment, the activity of Smurf1 was abrogated completely 
after 16 h (Figure 2(a), lane 4 vs lane 3, MDM2 panel). No-
tably, the abundance of Smurf1 was constant (lane 4 vs lane 
2, Smurf1 panel), indicating that Smurf1 stability was not 
regulated by DNA damage. In addition, depletion of 
Smurf1/2 by RNA interference (RNAi) resulted in an in-
crease of cell apoptosis (Figure 2(b), top panels), possibly 
due to the increased p53 activity as we previously showed [10]. 
Upon etoposide treatment for 24 h, the effect of Smurf1 de-
pletion on cell apoptosis was abolished (Figure 2(b), bottom  
 
Figure 1  Mapping the regions of Smurf1 required for MDM2 stabilization. The indicated Myc-tagged deletion mutants of Smurf1 were coexpressed with 
CMV-MDM2 in MCF7 cells, and the lysates were analyzed by immunoblotting with anti-MDM2 and anti-Myc antibodies (a). The effect of Smurf1 mutants 
on MDM2 stability was summarised in (b). GFP plasmid was co-transfected into the cells in all of the plasmid transfections. The expression of GFP was 
analyzed to indicate the transfection efficiency and GAPDH was used as the loading control.  
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Figure 2  The stabilizing effect of Smurf1 on MDM2 is abolished in response to DNA damage. (a) DNA damage stress abolished the stabilizing effect of 
Smurf1 on MDM2 protein. MCF7 cells, transfected with MDM2, control vector or Smurf1, were treated with DMSO or etoposide (40 μmol/L) for 16 h, 
harvested and analysed by IB with MDM2 antibody. ETO, etoposide. (b) Apoptosis analysis of untreated and etoposide-treated MCF7 cells transfected with 
Smurf1 and/or Smurf2-specific siRNAs. Annexin-V staining and flow cytometry analysis was performed to determine the cell apoptosis ratio. (c) MCF7 
cells, transfected with MDM2, control vector or Smurf1, were treated with etoposide for the indicated times, harvested and analysed by immunoblotting with 
anti-MDM2 and anti-Myc antibodies. (d) Myc-Smurf1 and CMV-MDM2 were co-transfected into MCF7 cells, treated with MG132 for 8 h before harvesting, 
together with etoposide (40 μmol/L) for the indicated times. Cell lysates were immunoprecipitated with anti-Myc antibody, and samples were detected by 
immunoblotting with anti-MDM2.  
panels). Collectively, Smurf1/2 activity on MDM2 stability 
control was negatively regulated by DNA damage stress. 
Next we asked whether this abrogation was a rapid or a 
slow response. Detailed time-course analysis showed that 
the attenuation effect of Smurf1 activity in response to 
etoposide treatment was a slow process (Figure 2(c)). As 
indicated, at 2, 4 and 6 h post-treatment with etoposide, 
Smurf1 still retained the ability to stabilize the MDM2 pro-
tein. It has been well-characterized that p53 was rapidly 
accumulated within 0.5 h in response to DNA damage and 
the MDM2 destabilization precedes p53 accumulation 
[16,17]. Therefore, the ectopic expression of Smurf1 should 
prevent the rapid accumulation and activation of p53 due to 
the slow destabilization of MDM2. 
To investigate how the MDM2 was released from 
Smurf1 control in response to DNA damage stresses, we 
examined the interaction between Smurf1 and MDM2 in the 
indicated times. Four hours after etoposide treatment, the 
interaction between Smurf1 and MDM2 was significantly 
reduced (Figure 2(d)), indicating a gradual dissociation of 
Smurf1 from MDM2.  
2.3  The N-lobe of Smurf1 HECT domain is involved in 
the dissociation of Smurf1 from MDM2 in response to 
DNA damage 
Next we utilized the deletion mutants of Smurf1 to explore 
the possible mechanism by which the stabilizing effect of 
Smurf1 on MDM2 was attenuated by etoposide. Like the 
case of full-length Smurf1, the stabilizing effect of WW2+ 
HECT (283–731) form of Smurf1 on MDM2 was also ab-
rogated by etoposide treatment (Figure 3(a), lane 7 vs lane 
6). Strikingly, deletion of the HECT N-lobe generated a 
mutant of Smurf1 which constitutively stabilized MDM2 
despite the etoposide treatment (Figure 3(a), lane 8). Half- 
life analysis of MDM2 showed that the 283-731-∆N mutant 
retained the strong ability to stabilize MDM2 and prolong 
the half-life of MDM2 even in the presence of etoposide 
(Figure 3(b)), implicating that the HECT N-lobe might in-
clude the information responsive to DNA damage.  
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Figure 3  The N-lobe of Smurf1 HECT domain is involved in the attenuation of Smurf1 activity in response to DNA damage. (a) MCF7 cells were co-
transfected with MDM2, Smurf1 WT or mutants, treated with etoposide for 2 h. The protein levels of MDM2 and Smurf1 WT or mutants were analyzed by 
immunoblotting. Both long and short time exposure data were shown. (b) MCF7 cells were cotransfected with MDM2, Smurf1 WT or mutants, treated with 
etoposide for 2 h, and then chased by cycloheximide (CHX) for the indicated times. The cell lysates were analyzed by immunoblotting. Both long and short 
time exposure data were shown.  
2.4  The correlation of Smurf1, Smurf2 and MDM2 
expressed in human cancer samples 
P53 functions as a potent tumor suppressor whereas MDM2 
as an oncoprotein. P53 gene has been found widely mutated 
in various tumors and MDM2 amplified in certain tumors. 
Given that Smurf1/2 stabilizes MDM2 and destabilizes p53, 
we hypothesized that Smurf1/2 might exhibit some onco-
genic activities. To gain further insights into the physiolog-
ical relevance of MDM2 regulation by Smurfs, we exam-
ined the levels of Smurf1, Smurf2 and MDM2 proteins in 
human cancer samples. Immunohistochemical staining of 
paired colorectal cancer (CC), esophageal squamous cell 
carcinoma (ESCC) and pancreatic cancer (PC) samples 
showed that Smurf1, Smurf2 and MDM2 were mainly lo-
calized in the cytoplasm of tumor cells (Figure 4). By anal-
ysis of the effective stained tissue samples, the expression 
of Smurf1 was found up-regulated in colorectal cancer 
(65.0%, 13/20), ESCC (78.1%, 25/32) and pancreatic cancer 
(87.5%, 21/24) tissues; Smurf2 was up-regulated in colo-
rectal cancer (85.0%, 17/20), ESCC (62.5%, 20/32) and 
pancreatic cancer (71.2%, 16/21); and MDM2 was also 
over-expressed in colorectal cancer (70.8%, 17/24), ESCC 
(68.8%, 22/32) and pancreatic cancer (66.7%, 16/24). Over-
all, Smurf1, Smurf2 and MDM2 were validated in 76, 73 
and 80 tumor patients with 3 different types of cancers, re-
spectively. The results showed that they were over-expressed 
in 77.6% (59/76), 72.6% (53/73) and 68.8% (55/80) tumor 
tissues, respectively (Table 1), indicating that Smurfs ex-
pression was correlated with MDM2. 
3  Discussion 
The tumor suppressor p53 protein is tightly regulated by the 
ubiquitin-proteasomal system. Several E3s, including MDM2  
 
Figure 4  The correlation of Smurfs and MDM2 expression in human cancer tissues. Representative immunohistochemical staining of MDM2, Smurf1 and 
Smurf2 in human cancer tissues. The representative fields from expression of Smurf1 (left), Smurf2 (middle) and MDM2 (right) in human colorectal cancer 
(CC), esophageal squamous cell carcinoma (ESCC) and pancreatic cancer (PC) tissues. Various cancer tissues (C1 & C2) and their normal tissues counter-
parts (N) were analyzed simultaneously and all photos were taken at 200× (N, C1) or 400× (C2). 
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[18], COP1 [19], JFK/FBXO42 [20], have been reported to 
mediated p53 ubiquitylation and degradation. The p53- 
MDM2 negative feedback loop constitutes the core module 
of a network of regulatory interactions activated under cel-
lular stress. In unstressed cells, the level of p53 protein is 
kept low mainly by MDM2, and MDM2 negatively regu-
lates the activity of p53. In response to DNA damage, ATM 
kinase is activated and phosphorylates both MDM2 and p53 
proteins, promoting the dissociation of MDM2-p53 and 
leading to p53 accumulation. The p53-mediated pathways 
are further activated by various post-translational modifica-
tions including phosphorylation and acetylation, leading to 
cell cycle arrest and repair of the DNA damage. If repair is 
not possible due to excessive damage, the p53-mediated 
apoptotic pathway is activated bringing about cell death 
[21]. In our previous study, we have proved that Smurf1/2 
does not bind with p53 directly but promotes p53 degrada-
tion by enhancing the stability of MDM2, and the regulation 
on MDM2 is not dependent on the E3 activity of Smurf1/2. 
Additionally, we found that Smurf1/2 inhibits cell apoptosis 
through p53 [10]. Here we show that in cells exposed to 
DNA damaging agents, overexpressed Smurf1 retained the 
ability to stabilize MDM2 protein in early stage. When the 
cells were exposed to DNA damage for a relative long time, 
the regulatory effects of Smurf1 on MDM2 stability and cell 
apoptosis were completely abolished. We further provided 
evidence that the N-terminal lobe of Smurf1 HECT domain 
contains the responsive element regulated by DNA damage. 
At the present stage, we do not exactly know the molecular 
mechanism by which Smurf1 was negatively regulated by 
DNA damage. Notably, the stability of Smurf1 protein was 
not affected significantly by DNA damage stress, both for 
the exogenous Smurf1 (Figure 2) and for the endogenous 
Smurf1 [22]. By contrast to DNA damage, the endoplasmic 
reticulum (ER) stress induced the proteasomal degradation 
of Smurf1 [22]. Although our data showed that DNA dam-
age treatment destroyed the interaction between Smurf1 and 
MDM2 in a slow manner, it was still unclear how DNA 
damage stress altered their interaction. There may be some 
post-translational modifications, or protein translocation 
which needs further investigations. 
MDM2 has been found amplified in human sarcomas. 
Amplification of the MDM2 gene is now reported in more 
than 10% of 8000 human cancers from various tissues, in-
cluding lung and stomach [23]. Both Smurf1 and Smurf2 
are key regulators in TGF- signaling pathway. Insensitivity 
to TGF- results in uncontrolled cell proliferation and con-
tributes to tumorigenesis. As Smurf1/2 are essential modu-
lators of the TGF- cascade, it is not surprising that dysreg-
ulation or dysfunction of Smurfs hampers TGF- signaling. 
Genetic amplification of Smurf1 and overexpression of 
Smurf2 are associated with pancreatic and esophageal 
squamous cell carcinomas, respectively [24]. Strikingly, we 
observed that Smurf1/2 overexpression occurs in colorectal 
cancer, esophageal squamous cell carcinoma and pancreatic 
cancer samples, consistent with the abnormal high expres-
sion of MDM2 in these cancers. We speculate Smurf1/2 and 
MDM2 may have overlapped function in regulating tumor 
development. And the stabilizing effects of Smurf1/2 on 
MDM2 might contribute to the high level of MDM2 in 
cancer tissues, which might alter the sensitivity of cancer 
cells to DNA damaging-drugs in cancer therapy. Whether 
Smurf1/2 belongs to the novel oncogenes and the patho-
physiological relevance between Smurf1/2 and MDM2 in 
cancers need deeper investigations in the future. 
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